Share-Based Payment (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment [Abstract]

Schedule of Share-Based Payment

For the years ended December 31, 2024 and 2023, the Company’s share-based payment transactions were as follows:

				Quantity
				granted
				(Units)		Contract		Vesting
Type of arrangement		Grant date		(Note 1)		Period		Conditions
Employee share options		2017.1.1		10,630		5 years		Note 2
Employee share options		2018.1.1		3,400		5 years		Note 2
Employee share options		2019.1.1		18,600		5 years		Note 2
Employee share options		2021.10.5		20,741		5 years		Note 3
Employee share options		2021.10.5		11,352		5 years		Note 2
Employee share options		2022.2.23		27,468		5 years		Note 2

Note 1:

Shares granted have been restated for the 10-to-1 reverse stock split effective April 15, 2024.

Note 2:

Employee share options granting period and exercise conditions are as follows:

				Quantity
				Granted
				(Ordinary shares)				Contract		Vesting
Type of arrangement		Grant date		(Note 1)				Period		Conditions
Obtain professional service through share-based payment		2022.12			5,388			Upon completion of services		Upon completion of services

				Quantity
				Granted
				(Ordinary				Contract		Vesting
Type of arrangement		Grant date		shares)				Period		Conditions
Obtain professional service through share-based payment		2024.10			6,371			Upon completion of services		Upon completion of services

Schedule of Employee Share Options Granting Period and Exercise Conditions

For the years ended December 31, 2024 and 2023, the Company’s share-based payment transactions were as follows:

		Accumulated maximum
		exercisable employee
Vesting period		share options
After 1 year			25	%
After 2 years			50	%
After 3 years			75	%
After 4 years			100	%

		Accumulated maximum
		exercisable employee
Vesting period		share options
At the beginning of year 1			25	%
At the beginning of year 2			50	%
At the beginning of year 3			75	%
At the beginning of year 4			100	%

Schedule of Share-Based Payment Arrangements

Share option activity under the Group’s stock-based compensation plans for employees is shown below:

		2024 (Note 1)								2023 (Note 1)
		No. of				Weighted average exercise				No. of				Weighted average exercise
		options				price				Options				Price
Options outstanding at January 1			51,879			$	11.66				255,164			$	11.66
Options granted			-				-				-				-
Options exercised			-				-				-				-
Options expired			-				-				(123,395	)			11.66
Options cancelled			(1,458	)			11.66				(79,890	)			11.66
Options forfeited			-				-				-				-
Options outstanding at December 31			50,421			$	11.66				51,879			$	11.66
Options exercisable at December 31			50,421			$	11.66				41,879			$	11.66

Note 1:

Shares options outstanding for the years and their exercise prices have been restated for the 10-to-1 reverse stock split effective April 15, 2024.

Note 2:

As of December 31, 2024 and 2023, the weighted-average remaining contractual period was 0.50 years and 1.50 years, respectively.

		2024 (Note 1)								2023 (Note 1)
		No. of				Weighted average fair Value				No. of				Weighted average fair Value
		Units				(Note 4)				Units				(Note 4)
Outstanding at January 1			38,833			$	3.03				-				-
Granted			38,484				7.69				142,741			$	5.93
Vested (Note 2)			(76,719	)			5.34				(103,908	)			7.02
Forfeited			(342	)			7.02				-				-
Outstanding at December 31			256			$	7.02				38,833			$	3.03

Note 1:

RSU’s outstanding for the years and their weighted average fair value have been restated for the 10-to-1 reverse stock split effective April 15, 2024.

Note 2:

As of December 31, 2024 and 2023, restricted stock units vested for which the underlying ordinary shares is yet to be issued are 11,545 and 3,818, respectively. For the years ended December 31, 2024 and 2023, restricted stock units for which the underlying ordinary shares were issued were 68,992 and 100,090, respectively.

Note 3:

As of December 31, 2024 and 2023, the weighted-average remaining contractual period was 1.90 years and 0.57 years, respectively.

Note 4:

The fair value of restricted stock units is the market price of the Company’s ordinary shares on the date of grant.

Schedule of Share-Based Compensation Employees

Expenses incurred on share-based compensation for employees is shown below:

		Year ended				Year ended				Year ended
		December 31, 2024				December 31, 2023				December 31, 2022
Share option expenses		$	-			$	203,676			$	346,122
RSU expenses			201,908				873,500				-
		$	201,908			$	1,077,176			$	346,122